PATENT CLAIM ANALYSIS

Application Number: 15968834
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
Compositions, vaccines and methods for inducing protective immunity against Human Immunodeficiency Virus (HIV) infection are described. Heterologous vaccine combinations of one or more viral expression vectors and an isolated antigenic polypeptide induced strong protective immunity against infections by one or multiple clades of HIV.

Claim (Index 13):
The method of  claim 12 , wherein the primer composition is re-administered at about 10-14 weeks after the primer composition is initially administered.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 93.0
- Lexical Diversity: 1.225
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14863808', '15693650', '15380123', '14632433', '14149549']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7264111179037293
- 35 USC 102 Novelty (BERT): 0.6619369558330459
- Combined Prediction Score: 0.7199637016966609
- Mean Citation Score: 489.17223600000005
- Max Citation Score: 746.9863
- Similarity Product: 585.7270484954238

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test